Bethany Johns
Director of Investor Relations
Replay available
European Wax Center, Inc. (NASDAQ: EWCZ) Q1 2025 earnings conference call, held 2025-05-14. Replay captured from the company's public earnings webcast.

Director of Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Telsey Advisory Group
Baird
Guggenheim
Piper Sandler
Citi
Morgan Stanley
Truist
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to European WAC Center's first quarter fiscal 2025 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. In order to facilitate as many participants as possible, we ask that you please limit yourself to one question and one follow-up during the Q&A session. If you have additional questions, you may rejoin the queue. On the call today are Chris Morris, Chairman and Chief Executive Officer, and Tom Kim, Chief Financial Officer. I would now like to turn the conference over to Bethany Johns, Director of Investor Relations. Ma'am, you may begin. Good morning, everyone. Thank you and welcome to European WAC Center's first quarter fiscal year 2025 earnings call. On today's call, Chris Morris will provide an update on his first full quarter with the company and discuss additional details regarding progress made on our priorities. Then, Tom will discuss our first quarter performance and fiscal 2025 outlook. Following the prepared remarks, the team will be available to take questions. Before we start, I would like to remind you of our legal disclaimer. We will make certain statements today which are forward-looking within the meaning of the federal securities laws, including statements about the outlook of our business and other matters referenced in our earnings release issued today. These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially. Please refer to our SEC filings as well as our earnings release issued today for a more detailed description of the risk factors that may affect our results. Please also note that these forward-loo...